logo
Finger-prick blood tests which quickly detect the deadliest type of stroke could save lives

Finger-prick blood tests which quickly detect the deadliest type of stroke could save lives

Yahoo10-03-2025

A finger-prick blood test to diagnose the deadliest form of stroke might be twice as effective at spotting it than using a patient's symptoms alone.
The test, which works similarly to a lateral flow test used to detect Covid, is being piloted by ambulance crews in Cambridgeshire.
The blood tests have been designed to detect if someone has suffered a large vessel occlusion (LVO), where a blood clot blocks a major artery in the brain.
This type of blood clot is responsible for about a third of strokes but causes about 95 per cent of disabilities and deaths.
A stroke is a very serious condition where the blood supply to part of your brain is cut off, and every minute a stroke is left untreated some 1.9 million brain cells die, increasing the risk of serious long-term disability and death, according to the Stroke Association.
But speedy treatment for a stroke can dramatically increase a patient's chances of recovery. This includes a thrombectomy procedure to remove the blood clot within a few hours of any symptoms appearing.
However, only 24 hospitals in the UK can provide thrombectomy treatment, and LVO is tricky to diagnose without a brain scan because it has similar symptoms to other conditions.
Due to a combination of NHS pressures and workforce shortages, these timeframes are often missed and only 3.9 per cent of eligible stroke patients had a thrombectomy in 2023/24 - against NHS England's target of 10 per cent by 2027/28.
In addition, only 46 per cent were admitted to a stroke unit within four hours of arriving at a hospital, which further reduces the treatment window and the patient's chances of recovery, the Stroke Association added.
As a result, unless a patient is lucky enough to live near a specialist centre, in most cases they will be taken to a general hospital. From there, it can take an average of three hours to be moved to a thrombectomy centre. However, these new finger-prick blood tests help diagnose LVOs faster and get patients the treatment they need.
The test, developed by the Cambridge-based firm UpFront Diagnostics, consists of two lateral flow cartridges and can detect two molecules in the blood.
One is a protein called D-dimer, which is associated with blood clots, and the other, called GFAP, is associated with bleeding in the brain. The absence of GFAP helps to rule out a haemorrhagic stroke where a blood vessel ruptures and bleeds, The Guardian reported.
These tests can detect LVOs with about 90 per cent accuracy within 15 minutes — which is more than double the accuracy of just checking symptoms, Gonzalo Ladreda, UpFront's chief executive officer, told the newspaper.
Dr Louise Flanagan, the head of research for the Stroke Association, which helps fund the early development of the LVOne test, told The Independent: 'When the NHS is under huge pressure and its workforce is in crisis, a simple finger prick test to help diagnose stroke could be revolutionary.
'The LVOne test could potentially diagnose stroke faster and much more affordably than the only current alternative, which is a brain scan. It could also help to identify the type of stroke a person is having, which is vital to ensure the right treatment is given.
'LVOne could help make it easier to decide whether someone is having a stroke that could be treated with a thrombectomy, saving the NHS time and money and, importantly, helping more people live well after stroke.'
The Stroke Association is calling for improvements in stroke care as part of the 10 Year Health Plan — to help meet the government's own target to reduce stroke disability and death by 25 per cent by 2035.
A Department of Health and Social Care spokesperson said: "This government is taking action to tackle the biggest killers like heart disease and strokes.
"We have introduced health checks in workplaces and blood pressure checks on high streets to help catch illness earlier, and we are acting to prevent strokes in the first place by tackling smoking and obesity.
"We are committed to improving stroke prevention, treatment, and recovery through our 10-Year Health Plan, which will emphasise prevention and make better use of innovative technology like prehospital video triage (PVT) as we shift the NHS from analogue to digital."
There are 1.3 million stroke survivors in the UK, and 100,000 people have strokes every year. But 90 per cent of these are preventable, the charity said. Lifestyle factors such as obesity, smoking, alcohol intake and exercise levels can have a significant effect on a person's stroke risk.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors

Business Upturn

time27 minutes ago

  • Business Upturn

PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors

San Francisco, June 10, 2025 (GLOBE NEWSWIRE) — PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program, enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians. This development marks a critical milestone in the company's mission to provide affordable, clinically supervised weight management across the United States. Accessible at the updated platform streamlines the process for eligible adults to consult with licensed physicians, receive lab work if necessary, and access customized treatment plans—all from the comfort of their homes. 'We're committed to making evidence-based weight loss solutions more accessible through modern telehealth,' said a PlushCare spokesperson. 'Our program is designed to connect people with experienced doctors who can evaluate eligibility for medications like GLP-1s and deliver a personalized plan that fits their health goals.' Expanded Features for 2025 The revamped Weight Loss Program now includes: Nationwide Access to medical providers via secure telehealth appointments to medical providers via secure telehealth appointments Eligibility Evaluation for FDA-approved medications, including semaglutide for FDA-approved medications, including semaglutide Personalized Plans tailored to each user's metabolic profile tailored to each user's metabolic profile Optional Lab Testing with integrated results for precision treatment with integrated results for precision treatment Transparent Pricing with no insurance required The platform is optimized for mobile and desktop users, offering a seamless experience from appointment scheduling to prescription delivery. Addressing a Growing National Health Concern According to the CDC, over 40% of U.S. adults struggle with obesity, with rising demand for effective clinical support. PlushCare's integrated virtual care model delivers a scalable solution that removes traditional geographic and scheduling barriers. Patients can typically get started in under 15 minutes by completing an intake form and booking a same-day appointment with a licensed doctor. If clinically appropriate, a prescription is sent to their preferred pharmacy. About PlushCare PlushCare is a virtual primary care and mental health platform that connects patients with top U.S. medical professionals through its secure telehealth platform. With a commitment to quality care, convenience, and evidence-based treatment, PlushCare is redefining access to modern healthcare. For more information, visit Media Contact:PlushCare Media Relations Email: [email protected] Website: Address: 345 California Street, Suite 600, San Francisco, CA 94105, United States

Experts warn of risks linked to period tracker apps
Experts warn of risks linked to period tracker apps

Yahoo

time2 hours ago

  • Yahoo

Experts warn of risks linked to period tracker apps

Women face 'real and frightening privacy and safety risks' when using period tracker apps, experts have warned. Academics from the University of Cambridge said that personal information in the app can be collected and 'sold at scale'. A new report from experts at Cambridge's Minderoo Centre for Technology and Democracy said that this 'poses risks and harms for users'. Researchers said that menstrual data can provide insights into people's health and their reproductive choices. These apps can collect information on exercise, diet, medication, sexual preferences, hormone levels and contraception use, they added. This information can be a 'gold mine' for consumer profiling, the authors of the new report said. Many women who download the apps do so when they are trying to get pregnant, which the authors point out leads to a dramatic shift in shopping behaviour. 'Data on who is pregnant, and who wants to be, has therefore emerged as some of the most sought-after information in digital advertising,' they said. The point out how period tracking apps have rapidly risen in popularity, with global downloads of the three most popular apps surpassing 250 million. 'Cycle tracking apps (CTA) are a lucrative business because they provide the companies behind the apps with access to extremely valuable and fine-grained user data,' the experts wrote in their new report. 'CTA data is not only commercially valuable and shared with an inextricable net if third parties (thereby making intimate user information exploitable for targeted advertising), but it also poses severe security risks for users.' They point out that in the wrong hands, the data collected by the apps could result in health insurance 'discrimination'; risks to job prospects or even domestic abuse. The research team called for better governance of the 'femtech' industry, including improved data security of these apps and for them to introduce 'meaningful consent options'. They also called for public health bodies to launch alternatives to commercial tracking apps. 'Menstrual cycle tracking apps are presented as empowering women and addressing the gender health gap,' said Dr Stefanie Felsberger, lead author of the report. 'Yet the business model behind their services rests on commercial use, selling user data and insights to third parties for profit.' 'There are real and frightening privacy and safety risks to women as a result of the commodification of the data collected by cycle tracking app companies.' Professor Gina Neff, executive director of Cambridge's Minderoo Centre, added: 'The use of cycle tracking apps is at an all-time high. 'Women deserve better than to have their menstrual tracking data treated as consumer data, but there is a different possible future.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Robotic surgeries set to soar under NHS plans
Robotic surgeries set to soar under NHS plans

Yahoo

time2 hours ago

  • Yahoo

Robotic surgeries set to soar under NHS plans

The use of robotic surgery is set to soar in the NHS in England under plans to expedite care for patients. In 2023/24, some 70,000 robot-assisted surgeries were carried out in the NHS in England, but the number is expected to rise to around half a million over the next decade. NHS officials said that by 2035, it is expected that nine in 10 of all keyhole surgeries will be delivered with robot assistance – up from one in five at present. Health Secretary Wes Streeting, who had robot-assisted surgery when he had treatment for kidney cancer, said that innovative technologies will 'transform the NHS'. NHS England said that patients who have robotic assisted-surgery tend to recover quicker and are able to leave hospital sooner. Experts said that robotic surgery allows 'greater dexterity and are easier to manipulate' compared to traditional surgery. Surgeons control instruments using a console and a camera. In some othopaedic procedures, robots are programmed to perform elements of procedures. Officials said that the range of robotic-assisted procedures has widened in recent years and spans multiple areas of medicine. Speaking ahead of a speech at the NHS ConfedExpo conference in Manchester, NHS England boss Sir Jim Mackey said: 'The NHS has pledged to return to shorter elective waiting times by 2029 and we are using every tool at our disposal to ensure patients get the best possible treatment. 'Expanding the use of new and exciting tech such as robotic surgery will play a huge part in this. 'Not only does it speed up the number of procedures the NHS can do, but it also means better outcomes, a faster recovery and shorter hospital stays for patients.' Mr Streeting said: 'Innovative treatments and technologies that help fast track better outcomes for patients is how we transform our NHS and make it fit for the future. 'I know myself how important this is, when the NHS saved my life from kidney cancer with an operation led by a world-class surgeon being helped by a robot. 'Whether it's robotic surgery, our new health data research service to accelerate the development of new medicines, or announcing new artificial intelligence that detects skin cancer, our Plan for Change is driving forward new ways to help cut waiting lists and get patients treated on time again.' John McGrath, consultant surgeon at North Bristol NHS Trust and chair of the NHSE Steering Committee for Robotic Assisted Surgery, added: 'Robot-assisted surgery is a perfect example of innovation improving patients' care and transforming the way the NHS works – the number of procedures being carried is set to rapidly grow over the next 10 years according to our analysis. 'As keyhole surgery continues to develop and scale up in the NHS, it is likely that many of these procedures will be provided with degrees of robot assistance in the future. 'Faster recovery and shorter hospital stays are not only hugely important benefits for patients undergoing surgery, if used efficiently they can have a positive impact on the rest of the system by relieving pressure on services and therefore helping to reduce waiting times.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store